1. Home
  2. TREE vs AKBA Comparison

TREE vs AKBA Comparison

Compare TREE & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$25.91

Market Cap

376.5M

Sector

Finance

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.91

Market Cap

343.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
AKBA
Founded
1996
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
376.5M
343.4M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
TREE
AKBA
Price
$25.91
$0.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$71.25
$4.67
AVG Volume (30 Days)
387.4K
8.9M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
93.94
EPS
1.90
N/A
Revenue
$1,117,324,000.00
N/A
Revenue This Year
$19.03
N/A
Revenue Next Year
$7.07
N/A
P/E Ratio
$13.69
N/A
Revenue Growth
24.12
N/A
52 Week Low
$25.98
$0.81
52 Week High
$74.53
$3.19

Technical Indicators

Market Signals
Indicator
TREE
AKBA
Relative Strength Index (RSI) 30.37 42.56
Support Level N/A $0.84
Resistance Level $39.74 $0.96
Average True Range (ATR) 1.03 0.06
MACD 0.15 0.00
Stochastic Oscillator 9.56 25.62

Price Performance

Historical Comparison
TREE
AKBA

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: